Literature DB >> 22996384

Severe anaphylaxis caused by orally administered vancomycin to a patient with Clostridium difficile infection.

D Bossé1, C Lemire, J Ruel, A M Cantin, F Ménard, L Valiquette.   

Abstract

We report the first case of anaphylaxis to oral vancomycin in a cystic fibrosis patient with severe and relapsing Clostridium difficile infection (CDI) refractory to metronidazole. The patient's colitis has been successfully treated with a combination of intravenous metronidazole and tigecycline.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22996384     DOI： 10.1007/s15010-012-0328-4

Source DB:  PubMed          Journal:  Infection        ISSN： 0300-8126            Impact factor:   3.553


  26 in total

1.  Intestinal colonisation and blood stream infections due to vancomycin-resistant enterococci (VRE) and extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBLE) in patients with haematological and oncological malignancies.

Authors:  B J Liss; J J Vehreschild; O A Cornely; M Hallek; G Fätkenheuer; H Wisplinghoff; H Seifert; M J G T Vehreschild
Journal:  Infection       Date:  2012-06-05       Impact factor: 3.553

2.  Anaphylaxis to topical bacitracin ointment.

Authors:  Karen Greenberg; James Espinosa; Victor Scali
Journal:  Am J Emerg Med       Date:  2007-01       Impact factor: 2.469

3.  European Society of Clinical Microbiology and Infectious Diseases (ESCMID): treatment guidance document for Clostridium difficile infection (CDI).

Authors:  M P Bauer; E J Kuijper; J T van Dissel
Journal:  Clin Microbiol Infect       Date:  2009-12       Impact factor: 8.067

4.  Multiple drug allergy syndrome: severe anaphylactic reaction due to topical rifamycin SV in a patient with hypersensitivity to ciprofloxacin.

Authors:  E Scala; M Giani; L Pirrotta; E C Guerra; O De Pità; P Puddu
Journal:  Int J Dermatol       Date:  2001-09       Impact factor: 2.736

5.  Studies on the mechanism of multiple drug allergies. Structural basis of drug recognition.

Authors:  N H Pham; B A Baldo; R M Puy
Journal:  J Immunoassay Immunochem       Date:  2001

6.  Perioperative anaphylaxis from locally applied rifamycin SV and latex.

Authors:  D G Ebo; G Verheecke; C H Bridts; C H Mertens; W J Stevens
Journal:  Br J Anaesth       Date:  2006-06       Impact factor: 9.166

7.  Failure of tigecycline to treat severe Clostridium difficile infection.

Authors:  P Kopterides; C Papageorgiou; A Antoniadou; E Papadomichelakis; I Tsangaris; I Dimopoulou; A Armaganidis
Journal:  Anaesth Intensive Care       Date:  2010-07       Impact factor: 1.669

8.  Allergic reactions associated with airborne fish particles in IgE-mediated fish hypersensitive patients.

Authors:  J F Crespo; C Pascual; C Dominguez; I Ojeda; F M Muñoz; M M Esteban
Journal:  Allergy       Date:  1995-03       Impact factor: 13.146

9.  Treatment of first recurrence of Clostridium difficile infection: fidaxomicin versus vancomycin.

Authors:  Oliver A Cornely; Mark A Miller; Thomas J Louie; Derrick W Crook; Sherwood L Gorbach
Journal:  Clin Infect Dis       Date:  2012-08       Impact factor: 9.079

10.  An elderly woman with 'Red Man Syndrome' in association with oral vancomycin therapy: a case report.

Authors:  Phillippa Bailey; Henry Gray
Journal:  Cases J       Date:  2008-08-18
View more
  8 in total

Review 1.  Antimicrobial stewardship's new weapon? A review of antibiotic allergy and pathways to 'de-labeling'.

Authors:  Jason Trubiano; Elizabeth Phillips
Journal:  Curr Opin Infect Dis       Date:  2013-12       Impact factor: 4.915

Review 2.  Does oral vancomycin use necessitate therapeutic drug monitoring?

Authors:  Nevio Cimolai
Journal:  Infection       Date:  2019-11-11       Impact factor: 3.553

Review 3.  Road Less Traveled: Drug Hypersensitivity to Fluoroquinolones, Vancomycin, Tetracyclines, and Macrolides.

Authors:  Linda J Zhu; Anne Y Liu; Priscilla H Wong; Anna Chen Arroyo
Journal:  Clin Rev Allergy Immunol       Date:  2022-01-29       Impact factor: 10.817

4.  Development of acute kidney injury during continuous infusion of vancomycin in septic patients.

Authors:  S Cianferoni; A Devigili; E Ocampos-Martinez; L Penaccini; S Scolletta; A Abdelhadii; D De Backer; M Beumier; F Jacobs; J-L Vincent; F S Taccone
Journal:  Infection       Date:  2013-04-10       Impact factor: 3.553

5.  Immunoglobulin E-mediated hypersensitivity reaction after intraperitoneal administration of vancomycin.

Authors:  Mun-Ju Hwang; Jun-Young Do; Eun-Woo Choi; Joon-Hyuk Seo; Yoon-Jung Nam; Kyung-Woo Yoon; Jong-Won Park; Kyu-Hyang Cho; Seok-Hui Kang; Hyun-Jung Jin
Journal:  Kidney Res Clin Pract       Date:  2014-12-05

Review 6.  Glycopeptide Hypersensitivity and Adverse Reactions.

Authors:  Vanthida Huang; Nicola A Clayton; Kimberly H Welker
Journal:  Pharmacy (Basel)       Date:  2020-04-21

7.  Prevention of Clostridium difficile spore formation by sub-inhibitory concentrations of tigecycline and piperacillin/tazobactam.

Authors:  Julian R Garneau; Louis Valiquette; Louis-Charles Fortier
Journal:  BMC Infect Dis       Date:  2014-01-15       Impact factor: 3.090

8.  Rash induced by enteral vancomycin therapy in an older patient in a long-term care ventilator unit: case report and review of the literature.

Authors:  Jeremy Barron; Adolfo Lattes; Esther-Lee Marcus
Journal:  Allergy Asthma Clin Immunol       Date:  2018-11-06       Impact factor: 3.406
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.